The health effects of vitamin C supplementation: a review.

References

• Block G, Patterson B, Subar A: Fruit, vegetables, and cancer prevention: a review of the epidemiological evidence. Nutr Cancer 18: 1–29, 1992.
   PubMed Web of Science ®Google Scholar
• Block G: The data support a role for antioxidants in reducing cancer risk. Nutr Rev 50: 207–213, 1992.
   PubMed Web of Science ®Google Scholar
• Bendich A, Machlin LJ, Scandurra O: The antioxidant role of vitamin C. Adv Free Radical Biol Med 2: 419–444, 1986.
   Web of Science ®Google Scholar
• Tannenbaum SR, Wishnok JS, Leaf CD: Inhibition of nitrosamine formation by ascorbic acid. Am J Clin Nutr 52: 247S–250S, 1991.
   Google Scholar
• Block G, Vitamin C status and cancer: Epidemiologic evidence of reduced risk. Ann NY Acad Sci 669: 280–290, 1992.
   PubMed Web of Science ®Google Scholar
• Howe GR, Hirohata T, Hislop TG, Iscovich JM, Yuan J-M, Katsouyanni K, Lubin F, Marubini E, Modan B, Rohan T, Toniolo P, Shunzhang Y: Dietary factors and risk of breast cancer: combined analysis of 12 case-control studies. JNCI 82: 561–569, 1990.
   PubMed Web of Science ®Google Scholar
• Blot WJ, Li J-Y, Taylor PR, Guo W, Dawsey S, Wang G-Q, Yang CS, Zheng S-F, Gail M, Li G-Y, Yu Y, Liu B-q, Tangrea J, Sun Y-h, Liu F, Fraumeni JF Jr, Zhang Y-H, Li B: Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence and disease-specific mortality in the general population. JNCI 85: 1483–1492, 1993.
   PubMed Web of Science ®Google Scholar
• Ruiz B, Rood JC, Fontham ETH, Malcom GT, Hunter FM, Soban M, Johnson WD, Correa P: Vitamin C concentration in gastric juice before and after anti-Helicobacter pylori treatment. Am J Gastroenterol 89: 533–539, 1994.
   PubMed Web of Science ®Google Scholar
• Banerjee S, Hawksby C, Miller S, Dahill S, Beattie AD, McColl KEL: Effect of Helicobacter pylori and its eradication on gastric juice ascorbic acid. Gut 35: 317–322, 1994.
   PubMed Web of Science ®Google Scholar
• Hwang H, Dwyer J, Russell RM: Diet, Helicobacter pylori infection, food preservation and gastric cancer risk: are there new roles for preventive factors? (Review) Nutr Rev 52: 75–83, 1994.
   PubMed Web of Science ®Google Scholar
• Enstrom JE, Kanim LE, Klein MA: Vitamin C intake and mortality among a sample of the United States population. Epidemiology 3: 194–202, 1992.
   PubMed Web of Science ®Google Scholar
• Herbert V: Does mega-C do more good than harm, or more harm than good? Nutr Today 28: 28–32, 1993.
   Google Scholar
• Enstrom JE: Counterviewpoint. Vitamin C and mortality. Nutr Today 28: 39–42, 1993.
   Google Scholar
• Stampfer MJ, Hennekens CH, Manson JE, Colditz GA, Rosner B, Willett WC: Vitamin E consumption and the risk of coronary disease in women. N Engl J Med 328: 1444–1449, 1993.
   PubMed Web of Science ®Google Scholar
• Rimm EB, Stampfer MJ, Ascherio A, Giovannucci E, Colditz GA, Willett WC: Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med 328: 1450–1456, 1993.
   PubMed Web of Science ®Google Scholar
• Gey KF, Stähelin HB, Eichholzer M: Poor plasma status of carotene and vitamin C is associated with higher mortality from ischemic heart disease and stroke: Basel Prospective Study. Clin Invest 71: 3–6, 1993.
   PubMedGoogle Scholar
• Simon JA: Vitamin C and cardiovascular disease: a review. J Am Coll Nutr 11: 107–125, 1992.
   PubMed Web of Science ®Google Scholar
• Trout DL: Vitamin C and cardiovascular risk factors. Am J Clin Nutr 53: 322S–325S, 1991.
   PubMed Web of Science ®Google Scholar
• Jacques PF: Effects of vitamin C on high-density lipoprotein cholesterol and blood pressure. J Am Coll Nutr 11: 139–144, 1992.
   PubMed Web of Science ®Google Scholar
• Hallfrisch J, Singh VN, Muller DC, Baldwin H, Bannon ME, Andres R: High plasma vitamin C associated with high plasma HDL- and HDL2-cholesterol. Am J Clin Nutr 60: 100–105, 1994.
   PubMed Web of Science ®Google Scholar
• Jacques PF: Relationship of vitamin C status to cholesterol and blood pressure. Ann NY Acad Sci 669: 205–213, 1992.
   PubMed Web of Science ®Google Scholar
• Dallal GE, Choi E, Jacques P, Schaefer EJ, Jacob RA: Ascorbic acid, HDL cholesterol, and apolipoprotein A-I in an elderly Chinese population in Boston. J Am Coll Nutr 8: 69–74, 1989.
   PubMed Web of Science ®Google Scholar
• Jacques PF, Hartz SC, McGandy RB, Jacob RA, Russell RM: Ascorbic acid, HDL, and total plasma cholesterol in the elderly. J Am Coll Nutr 6: 169–174, 1987.
   PubMed Web of Science ®Google Scholar
• Bates CJ, Burr MK, St Leger AS: Vitamin C, high-density lipoproteins and heart disease in elderly subjects. Age Ageing 8: 177–182, 1979.
   PubMed Web of Science ®Google Scholar
• Burr ML, Bates CJ, Milbank JE, Yarnell JWC: The relationship between plasma ascorbate and lipid concentrations in fasting men. Hum Nutr Clin Nutr 36C: 135–139, 1982.
   Google Scholar
• Burr ML, Bates CJ, Sweetnam PM, Barasi ME: Plasma ascorbate and HDL-cholesterol in women. Hum Nutr Clin Nutr 36C: 399–400, 1982.
   Google Scholar
• Retsky KL, Freeman MW, Frei B: Ascorbic acid oxidation product(s) protect human low density lipoprotein against atherogenic modification. J Biol Chem 268: 1304–1309, 1993.
   PubMed Web of Science ®Google Scholar
• Moran JP, Cohen L, Greene JM, Xu G, Feldman EB, Hames CG, Feldman DS: Plasma ascorbic acid concentrations relate inversely to blood pressure in human subjects. Am J Clin Nutr 57: 213–217, 1993.
   PubMed Web of Science ®Google Scholar
• Ascherio A, Stampfer MJ, Colditz GA, Willett WC, McKinlay J: Nutrient intakes and blood pressure in normotensive males. Int J Epidemiol 20: 886–891, 1991.
   PubMed Web of Science ®Google Scholar
• Salonen JT, Salonen R, Ihanainen M, Parviainen M, Seppänen R, Kantola M, Seppänen K, Rauramaa R: Blood pressure, dietary fats, and antioxidants. Am J Clin Nutr 48: 1226–1232, 1988.
   PubMed Web of Science ®Google Scholar
• Salonen JT, Salonen R, Ihanainen M, Parviainen M, Seppänen R, Seppänen K, Rauramaa R: Vitamin C deficiency and low lino-lenate intake associated with elevated blood pressure: the Kuopio Ischaemic Heart Disease Risk Factor Study. J Hypertension 5: S521–S524, 1987.
   Google Scholar
• Yoshioka M, Matsushita T, Chuman Y: Inverse association of serum ascorbic acid level and blood pressure on rate of hypertension in male adults aged 30–39 years. Int J Vit Nutr Res 54: 343–347, 1984.
   PubMed Web of Science ®Google Scholar
• McCarron DA, Morris CD, Henry HJ, Stanton JL: Blood pressure and nutrient intake in the United States. Science 224: 1392–1398, 1984.
   PubMed Web of Science ®Google Scholar
• Koh ET, Chi MS: Relationship of serum vitamin C and globulin fractions with anthropometric measurements in adults. Nutr Rep Int 21: 537–549, 1980.
   Google Scholar
• Koh ET, Stewart T: Interrelationship among the blood components and anthropometric measurements. Nutr Rep Int 18: 539–548, 1978.
   Google Scholar
• Koh ET: Effect of vitamin C on blood parameters of hypertensive subjects. J Okla State Med Assoc 77: 177–182, 1984.
   PubMedGoogle Scholar
• Feldman EB, Gold S, Greene J, Moran J, Xu G, Shultz GG, Hames CG, Feldman DS: Ascorbic acid supplements and blood pressure. A four-week pilot study. In Sauberlich HE, Machlin LJ (eds): “Beyond Deficiency: New Views on the Function and Health Effects of Vitamins,” Vol. 669. New York: Annals NY Academy of Sciences, pp 342–344, 1992.
   Google Scholar
• Taylor A: Cataract: relationships between nutrition and oxidation. J Am Coll Nutr 12: 138–146, 1993.
   PubMed Web of Science ®Google Scholar
• Robertson JM, Donner AP, Trevithick JR: Vitamin E intake and risk of cataracts in humans. Ann NY Acad Sci 570: 372–382, 1989.
   PubMed Web of Science ®Google Scholar
• Leske MC, Chylack LT Jr, Wu S-Y: The lens opacities case-control study group. The lens opacities case-control study. Risk factors for cataract. Arch Ophthalmol 109: 244–251, 1991.
   PubMed Web of Science ®Google Scholar
• Seddon JM, Christen WG, Manson JE, La Motte FS, Glynn RJ, Buring JE, Hennekens CH: The use of vitamin supplements and the risk of cataract among US male physicians. Am J Pub Health 84: 788–792, 1994.
   PubMed Web of Science ®Google Scholar
• Jacques PF, Chylack LT Jr: Epidemiologic evidence of a role for the antioxidant vitamins and carotenoids in cataract prevention. Am J Clin Nutr 53: 352S–355S, 1991.
   PubMed Web of Science ®Google Scholar
• Hankinson SE, Stampfer MJ, Seddon JM, Colditz A, Rosner B, Speizer FE, Willett WC: Nutrient intake and cataract extraction in women: a prospective study. Br Med J 305: 335–339, 1992.
   PubMed Web of Science ®Google Scholar
• Vitale S, West S, Hallfrisch J, Alston C, Wang F, Moorman C, Muller D, Singh V, Taylor HR: Plasma antioxidants and risk of cortical and nuclear cataract. Epidemiology 4: 195–203, 1993.
   PubMed Web of Science ®Google Scholar
• Blumenkranz MS, Russell SR, Robey MG, Kott-Blumenkranz R, Penneys N: Risk factors in age-related maculopathy complicated by choroidal neovascularization. Opthalmology 93: 552–557, 1986.
   PubMed Web of Science ®Google Scholar
• Goldberg J, Flowerdew G, Smith E, Brody JA, Tso MOM: Factors associated with age-related macular degeneration: an analysis of data from the First National Health and Nutrition Examination Survey. Am J Epidemiol 128: 700–710, 1988.
   PubMed Web of Science ®Google Scholar
• Schlach W: Carotenoids in the retina—a review of their possible role in preventing or limiting damage caused by light and oxygen. In Emerit I, Chance B (eds): “Free Radicals and Aging.” Basel, Switzerland: Birkhäuser Verlag, pp 280–298, 1992.
   Google Scholar
• Eye Disease Case-Control Study Group: Antioxidant status and neovascular age-related macular degeneration. Arch Opthalmol 111: 104–109, 1993.
   PubMed Web of Science ®Google Scholar
• Fraga CG, Motchnik PA, Shigenaga MK, Helbock HJ, Jacob RA, Ames BN: Ascorbic acid protects against endogenous oxidative DNA damage in human sperm. Proc Natl Acad Sci USA 88: 11003–11006, 1991.
   PubMed Web of Science ®Google Scholar
• Dawson EB, Harris WA, Teter MC, Powell LC: Effect of ascorbic acid supplementation on the sperm quality of smokers. Fertility & Sterility 58: 1034–1039, 1992.
   PubMed Web of Science ®Google Scholar
• Hemilä H: Vitamin C and the common cold. Br J Nutr 67: 3–16, 1992.
   PubMed Web of Science ®Google Scholar
• Peters EM, Goetzsche JM, Grobbelaar B, Noakes TD: Vitamin C supplementation reduces the incidence of postrace symptoms of upper-respiratory-tract infection in ultramarathon runners. Am J Clin Nutr 57: 170–174, 1993.
   PubMed Web of Science ®Google Scholar
• Bendich A: Ascorbic acid and immune functions. In Wenk C, Fenster R, Volker L (eds): “Ascorbic Acid in Domestic Animals.” Zurich, Switzerland: Institut für Nutztierwissenschaften: pp 408–421, 1992.
   Google Scholar
• Bucca C, Rolla G, Farina JC: Effect of vitamin C on transient increase of bronchial responsiveness in conditions affecting the airways. Ann NY Acad Sci 669: 175–186, 1992.
   PubMed Web of Science ®Google Scholar
• Schwartz J, Weiss ST: Dietary factors and their relation to respiratory symptoms. The Second National Health and Nutrition Examination Survey. Am J Epidemiol 132: 67–76, 1990.
   PubMed Web of Science ®Google Scholar
• Schwartz J, Weiss ST: Relationship between dietary vitamin C intake and pulmonary function in the First National Health and Nutrition Examination Survey (NHANES I). Am J Clin Nutr 59: 110–114, 1994.
   PubMed Web of Science ®Google Scholar
• Rivers JM: Safety of high-level vitamin C ingestion. Ann NY Acad Sci 498: 445–454, 1987.
   PubMed Web of Science ®Google Scholar
• Hathcock JN: Safety of vitamin and mineral supplements. In Bendich A, Butterworth CE, (eds): “Micronutrients in Health and in Disease Prevention.” New York: Marcel Dekker, Inc, pp 439–450, 1991.
   Google Scholar
• Gerster H: Do high doses of vitamin C cause kidney stones? Nutrition/Ernährung 10: 614–617, 1986.
   Google Scholar
• Gerster H, Moser U: Is high dose vitamin C intake associated with systemic conditioning? Nutr Res 8: 1327–1332, 1988.
   Web of Science ®Google Scholar
• Gaby SK, Singh VN: Vitamin C. In Gaby SK, Bendich A, Singh VN, Machlin LJ (eds): “Vitamin Intake and Health. A Scientific Review.” New York: Marcel Dekker, Inc, pp 103–161, 1991.
   Google Scholar
• Bendich A: Safety issues regarding the use of vitamin supplements. Ann NY Acad Sci 669: 300–310, 1992.
   PubMed Web of Science ®Google Scholar
• Subcommittee on the Tenth Edition of the RDAs, Food and Nutrition Board, National Research Council: “Recommended Dietary Allowances,” 10th ed. Washington, DC: National Academy Press, 1989.
   Google Scholar
• Herbert V, Jacob E: Destruction of vitamin B12 by ascorbic acid. JAMA 230: 241–242, 1974.
   PubMed Web of Science ®Google Scholar
• Herbert V, Jacob E, Wong KTJ, Scott J, Pfeffer RD: Low serum vitamin B12 levels in patients receiving ascorbic acid in megadoses: studies concerning the effect of ascorbate on radioisotope vitamin B12 assay. Am J Clin Nutr 31: 253–258, 1978.
   PubMed Web of Science ®Google Scholar
• Marcus M, Prabhudesai M, Wassef S: Stability of vitamin B12 in the presence of ascorbic acid in food and serum: restoration by cyanide of apparent loss. Am J Clin Nutr 33: 137–143, 1980.
   PubMed Web of Science ®Google Scholar
• Stich HF, Karim J, Koropatnick J, Lo L: Mutagenic action of ascorbic acid. Nature 260: 722–724, 1976.
   PubMed Web of Science ®Google Scholar
• Norkus EP, Kuenzig WA, Conney AH: Studies on the mutagenic activity of ascorbic acid in vitro and in vivo. Mutation Res 117: 183–191, 1983.
   PubMed Web of Science ®Google Scholar
• Galloway SM, Painter RB: Vitamin C is positive in the DNA synthesis inhibition and sister-chromatid exchange tests. Mutation Res 60: 321–327, 1979.
   PubMed Web of Science ®Google Scholar
• Alzieu P, Cassand P, Colin C, Grolier P, Narbonne JF: Effect of vitamins A, C and glutathione on the mutagenicity of benzo-[a]pyrene mediated by S9 from vitamin A-deficient rats. Mutation Res 192: 227–231, 1987.
   PubMed Web of Science ®Google Scholar
• Sram RJ, Dobias L, Pastorkova A, Rossner P, Janca L: Effect of ascorbic acid prophylaxis on the frequency of chromosome aberrations in the peripheral lympocytes of coal-tar workers. Mutation Res 120: 181–186, 1983.
   PubMed Web of Science ®Google Scholar
• Sram RJ, Samkova I, Hola N: High-dose ascorbic acid prophylaxis in workers occupationally exposed to halogenated ethers. J Hygiene Epidemiol Microbiol Immunol 27: 305–318, 1983.
   PubMedGoogle Scholar
• Sram RJ, Cerna M, Hola N: Effect of ascorbic acid prophylaxis in groups occupationally exposed to mutagens. Prog Clin Biol Res 209B: 327–335, 1986.
   PubMedGoogle Scholar
• Rhead WJ, Schrauzer GN: Risks of long-term ascorbic acid overdosage. Nutr Rev 11: 262–263, 1971.
   Google Scholar
• Siegel C, Barker B, Kunstadter M: Conditional oral scurvy due to megavitamin C withdrawal. J Periodontal 53: 453–455, 1982.
   PubMed Web of Science ®Google Scholar
• Tsao CS, Salimi SL: Evidence of rebound effect with ascorbic acid. Med Hypotheses 13: 303–310, 1984.
   PubMed Web of Science ®Google Scholar
• Cochrane WA: Overnutrition in prenatal and neonatal life: a problem? Can Med Assoc J 93: 893–899, 1965.
   PubMed Web of Science ®Google Scholar
• Hornig DH, Moser U: The safety of high vitamin C intake in man. In Counsell JN, Hornig DH (eds): “Vitamin C (Ascorbic Acid).” Englewood, NJ: Applied Science Publishers, pp 225–248, 1981.
   Google Scholar
• Omaye ST, Skala JH, Jacob RA: Plasma ascorbic acid in adult males: effects of depletion and supplementation. Am J Clin Nutr 44: 257–264, 1986.
   PubMed Web of Science ®Google Scholar
• Omaye ST, Skala JH, Jacob RA: Rebound effect with ascorbic acid in adult males. Am J Clin Nutr 48: 379–381, 1988.
   PubMed Web of Science ®Google Scholar
• Benton D: The influence of large doses of vitamin C on psychological functioning. Psychopharmacology 75: 98–99, 1981.
   PubMed Web of Science ®Google Scholar
• Pascoe PA, Stone BM: Ascorbic acid and performance in man. Psychopharmacology 83: 376–377, 1984.
   PubMed Web of Science ®Google Scholar
• Finley EB, Cerklewski FL: Influence of ascorbic acid supplementation on copper status in young adult men. Am J Clin Nutr 37: 553–556, 1983.
   PubMed Web of Science ®Google Scholar
• Jacob RA, Skala JH, Omaye ST, Turnlund JR: Effect of varying ascorbic acid intakes on copper absorption and ceruloplasmin levels of young men. J Nutr 117: 2109–2115, 1987.
   PubMed Web of Science ®Google Scholar
• Milne DB, Klevay LM, Hunt JR: Effects of ascorbic acid supplements and a diet marginal in copper on indices of copper nutriture in women. Nutr Res 8: 865–873, 1988.
   Web of Science ®Google Scholar
• Schmidt K-H, Hagmaier V, Hornig DH, Vuilleumier J-P, Rutishauser G: Urinary oxalate excretion after large intakes of ascorbic acid in man. Am J Clin Nutr 34: 305–311, 1981.
   PubMed Web of Science ®Google Scholar
• Sutton JL, Basu TK, Dickerson JWT: Effect of large doses of ascorbic acid in man on some nitrogenous components of urine. Hum Nutr Appl Nutr 37A: 136–140, 1983.
   Google Scholar
• Hoffer A: Ascorbic acid and kidney stones. Can Med Assoc J 132: 320, 1985.
   PubMed Web of Science ®Google Scholar
• Erden F, Hacisalihoglu A, Kocer Z, Simsek B, Nebioglu S: Effects of vitamin C intake on whole blood plasma, leucocyte and urine ascorbic acid and urine oxalic acid levels. Acta Vitaminol Enzymol 7: 123–130, 1985.
   PubMedGoogle Scholar
• Singh PP, Sharma DC, Rathore V, Surana SS: An investigation into the role of ascorbic acid in renal calculogenesis in albino rats. J Urol 139: 156–157, 1988.
   PubMed Web of Science ®Google Scholar
• Wandzilak TR, D'Andre SD, Davis PA, Williams HE: Effects of high dose vitamin C on urinary oxalate levels. J Urol 151: 834–837, 1994.
   PubMed Web of Science ®Google Scholar
• Campbell G, Steinberg M, Bower D: Ascorbic acid-induced hemolysis in G-6-PD deficiency. Ann Intern Med 82: 810, 1975.
   PubMed Web of Science ®Google Scholar
• Rees DC, Kelsey H, Richards JDM: Acute haemolysis induced by high dose ascorbic acid in glucose-6-phosphate dehydrogenase deficiency. Br Med J 306: 841–842, 1993.
   PubMed Web of Science ®Google Scholar
• Mehta JB, Singal SB, Meutch BC: Ascorbic-acid-induced haemolysis in G-6-PD deficiency. Lancet 336: 944, 1990.
   PubMed Web of Science ®Google Scholar
• Strijdom JG, Marais BJ, Koeslag JH: Ascorbic acid causes spuriously low blood glucose measurements. S Afr Med J 83: 64–65, 1993.
   PubMed Web of Science ®Google Scholar
• Hornig DH, Moser U, Glatthaar BE: Ascorbic acid. In Shils ME, Young VR (eds): “Modern Nutrition in Health and Disease,” 7th ed. Philadelphia: Lea & Febiger, pp 417–435, 1988.
   Google Scholar
• Moertel CG, Flemming RT, Creagan ET, Rubin J, O'Connell MJ, Ames MM: High dose vitamin C versus placebo in the treatment of patients with advanced cancer who have had no prior chemotherapy. N Engl J Med 312: 137–141, 1985.
   PubMed Web of Science ®Google Scholar
• Ludvigsson J, Hansson L-O, Stendahl O: The effect of large doses of vitamin C on leukocyte function and some laboratory parameters. Int J Vitam Nutr Res 49: 160–165, 1979.
   PubMed Web of Science ®Google Scholar
• Bussey HJR, DeCosse JJ, Deschner EE, Eyers AA, Lesser ML, Morson BC, Ritchie SM, Thomson JPS, Wadsworth J: A randomized trial of ascorbic acid in polyposis coli. Cancer 50: 1434–1439, 1982.
   PubMed Web of Science ®Google Scholar
• Bordia A, Verma SK: Effect of vitamin C on platelet adhesiveness and platelet aggregation in coronary artery disease patients. Clin Cardiol 8: 552–554, 1985.
   PubMed Web of Science ®Google Scholar
• Taylor A, Jacques PF, Nadler D, Morrow F, Sulsky SI, Sheppard D: Relationship in humans between ascorbic acid consumption and levels of total and reduced ascorbic acid in lens, aqueous humor, and plasma. Curr Eye Res 10: 751–759, 1991.
   PubMed Web of Science ®Google Scholar
• Bucca C, Rolla G, Oliva A, Farina JC: Effect of vitamin C on histamine bronchial responsiveness of patients with allergic rhinitis. Ann Allergy 65: 311–314, 1990.
   PubMedGoogle Scholar
• Osilesi OD, Trout L, Ogunwole JO, Glover EE: Blood pressure and plasma lipids during ascorbic acid supplementation in borderline hypertensive and normotensive adults. Nutr Res 11: 405–412, 1991.
   Web of Science ®Google Scholar
• McKeown-Eyssen G, Holloway C, Jazmaji V, Bright-See E, Dion P, Bruce WR: A randomized trial of vitamins C and E in the prevention of recurrence of colorectal polyps. Cancer Res 48: 4701–4705, 1988.
   PubMed Web of Science ®Google Scholar
• Lux B, May P: Long-term observation of young cystinuric patients under ascorbic acid therapy. Urol Int 38: 91–94, 1983.
   PubMed Web of Science ®Google Scholar
• Brox AG, Howson-Jan K, Fauser AA: Treatment of idiopathic thrombocytopenic purpura with ascorbate. Br J Haematol 70: 341–344, 1988.
   PubMed Web of Science ®Google Scholar
• Verhoef GEG, Boonen S, Boogaerts MA: Ascorbate for the treatment of refractory idiopathic thrombocytopenic purpura. Br J Haematol 74: 234, 1990.
   PubMed Web of Science ®Google Scholar
• Godeau B, Bierling P: Treatment of chronic autoimmune thrombocytopenic purpura with ascorbate. Br J Haematol 75: 289–290, 1990.
   PubMed Web of Science ®Google Scholar
• Melethil SW, Mason D, Chang C-J: Dose-dependent absorption and excretion of vitamin C in humans. Int J Pharmacol 31: 83–89, 1986.
   Google Scholar
• Reaven PD, Khouw A, Beltz WF, Parthasarathy S, Witztum JL: Effect of dietary antioxidant combinations in humans. Protection of LDL by vitamin E but not by β-carotene. Arteriosclerosis and Thrombosis 13: 590–600, 1993.
   PubMed Web of Science ®Google Scholar
• U.S. Department of Health and Human Services: “Nutrition Monitoring in the United States. An Update Report on Nutrition Monitoring.” Hyattsville, MD: Federation of American Societies for Experimental Biology, pp 64–65, 1989.
   Google Scholar
• U.S. Department of Health and Human Services: “Healthy people 2000. National health promotion and disease prevention objectives.” Washington, DC: U.S. Government Printing Office, pp 122–123, 1991.
   Google Scholar
• Johnson MA, Fischer JG, Bowman BA, Gunter EW: Iron nutriture in elderly individuals. FASEB 8: 609–621, 1994.
   PubMed Web of Science ®Google Scholar
• U.S. Department of Health and Human Services: “The Surgeon General's Report on Nutrition and Health.” Washington, DC: U.S. Government Printing Office, pp 16–17, 1988.
   Google Scholar
• Fairbanks VF, Beutler E: Iron. In Shils ME, Young VR (eds) “Modern Nutrition in Health and Disease,” 7th ed. Philadelphia: Lea & Febiger, pp 193–226, 1988.
   Google Scholar
• Brown EB: Recognition and treatment of iron overload. Adv Intern Med 26: 159–186, 1981.
   Google Scholar
• Moore CV, Dubach R: Observations on the absorption of iron from foods tagged with radioiron. Trans Assoc Am Physicians 64: 245–246, 1951.
   PubMedGoogle Scholar
• Monsen ER, Hallberg L, Layrisse M, Hegsted DM, Cook JD, Mertz W, Finch CA: Estimation of available dietary iron. Am J Clin Nutr 31: 134–141, 1978.
   PubMed Web of Science ®Google Scholar
• Monsen ER: Iron nutrition and absorption: dietary factors which impact iron bioavailability. J Am Diet Assoc 88: 786–790, 1988.
   PubMed Web of Science ®Google Scholar
• Hallberg L: Effect of vitamin C on the bioavailability of iron from food. In Counsell JN, Hornig DH (eds): “Vitamin C (Ascorbic Acid).” Englewood, NJ: Applied Science Publishers, pp 49–61, 1981.
   Google Scholar
• Hallberg L: The role of vitamin C in improving the critical iron balance situation in women. Int J Vitam Nutr Res 27(suppl):172–187, 1985.
   Google Scholar
• Sayers MH, Lynch SR, Charlton RW, Bothwell TH, Walker RB, Mayet F: Iron absorption from rice meals cooked with fortified salt containing ferrous sulfate and ascorbic acid. Br J Nutr 31: 367–375, 1974.
   PubMed Web of Science ®Google Scholar
• Bendich A, Cohen M: Ascorbic acid safety: analysis of factors affecting iron absorption. Toxicol Lett 51: 189–201, 1990.
   PubMed Web of Science ®Google Scholar
• Herbert V: Everyone should be tested for iron disorders. J Am Diet Assoc 92: 1502–1509, 1992.
   PubMed Web of Science ®Google Scholar
• Nienhuis AW, Griffith P, Strawczynski H, Henry W, Borer J, Leon M, Anderson WF: Evaluation of cardiac function in patients with thalassemia major. Ann NY Acad Sci 344: 384–396, 1980.
   PubMedGoogle Scholar
• McLaran CJ, Bett JHN, Nye JA, Halliday JW: Congestive cardiomyopathy and haemochromatosis—rapid progression possibly accelerated by excessive ingestion of ascorbic acid. Aust NZ J Med 12: 187–188, 1982.
   PubMedGoogle Scholar
• Rowbotham B, Roeser HP: Iron overload associated with congenital pyruvate kinase deficiency and high dose ascorbic acid ingestion. Aust NZ J Med 14: 667–669, 1984.
   PubMedGoogle Scholar
• Rouault TA: Hereditary hemochromatosis. JAMA 269: 3152–3154, 1993.
   PubMed Web of Science ®Google Scholar
• Edwards CQ, Kushner JP: Screening for hemochromatosis. N Engl J Med 328: 1616–1620, 1993.
   PubMed Web of Science ®Google Scholar
• Salonen JT, Nyyssönen K, Korpela H, Tuomilehto J, Seppanen R, Salonen R: High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men. Circulation 86: 803–811, 1992.
   PubMed Web of Science ®Google Scholar
• Fackelmann KA: Excess iron linked to heart disease. Sci News 142: 180, 1992.
   Google Scholar
• Sullivan JL: Stored iron and ischemic heart disease: empirical support for a new paradigm. Circulation 86: 1036–1037, 1992.
   PubMed Web of Science ®Google Scholar
• Weiss G, Reibnegger G, Murr C, Wächter H, Fuchs D: Iron linked to immune activation. Br Med J 307: 1067, 1993.
   PubMedGoogle Scholar
• Beard JL: Are we at risk for heart disease because of normal iron status? Nutr Rev 51: 112–115, 1993.
   PubMed Web of Science ®Google Scholar
• Morrison HI, Semenciw RM, Mao Y, Wigle DT: Serum iron and risk of fatal acute myocardial infarction. Epidemiology 5: 243–246, 1994.
   PubMed Web of Science ®Google Scholar
• Ascherio A, Willett WC, Rimm EB, Giovannucci EL, Stampfer MJ: Dietary iron intake and risk of coronary disease among men. Circulation 89: 969–974, 1994.
   PubMed Web of Science ®Google Scholar
• Sempos CT, Looker AC, Gillum RF, Makuc DM: Body iron stores and the risk of coronary heart disease. N Engl J Med 330: 1119–1124, 1994.
   PubMed Web of Science ®Google Scholar
• Riemersma RA, Wood DA, MacIntyre CCA, Elton RA, Gey KF, Oliver MF: Anti-oxidants and pro-oxidants in coronary heart disease. Lancet 337: 677, 1991.
   PubMed Web of Science ®Google Scholar
• Riemersma RA, Wood DA, MacIntyre CCA, Elton RA, Gey KF, Oliver MF: Risk of angina pectoris and plasma concentrations of vitamins A, C, and E and carotene. Lancet 337: 1–5, 1991.
   PubMed Web of Science ®Google Scholar
• Stampfer MJ, Grodstein F, Rosenberg I, Willett W, Hennekens C: A prospective study of plasma ferritin and risk of myocardial infarction in U.S. physicians. Circulation 87: 688, 1993.
   Web of Science ®Google Scholar
• Aronow WS: Serum ferritin is not a risk factor for coronary artery disease in men and women aged ≥ 62 years. Am J Cardiology 72: 347–348, 1993.
   PubMed Web of Science ®Google Scholar
• Mänttäri M, Manninen V, Huttunen JK, Heinonen OP, Frick MH: Serum ferritin and ceruloplasmin as coronary risk factors—a nested case-control study in the Helsinki heart study population. Circulation 88: 1–70, 1993.
   Web of Science ®Google Scholar
• Miller M, Hutchins GM: Is iron overload a risk factor for coronary artery disease? Circulation 88: 1–636, 1993.
   Google Scholar
• Magnusson MK, Sigfusson N, Sigvaldason H, Johannesson GM, Magnusson S, Thorgeirsson G: Low iron-binding capacity as a risk factor for myocardial infarction. Circulation 89: 102–108, 1994.
   PubMed Web of Science ®Google Scholar
• Ascherio A, Willett WC: Are body iron stores related to the risk of coronary heart disease? N Engl J Med 330: 1152–1153, 1994.
   PubMed Web of Science ®Google Scholar
• Burt MJ, Halliday JW, Powell LW: Iron and coronary heart disease. Br Med J 307: 575–576, 1993.
   PubMedGoogle Scholar
• Schectman G, Byrd JC, Hoffmann R: Ascorbic acid requirements for smokers: analysis of a population survey. Am J Clin Nutr 53: 1466–1470, 1991.
   PubMed Web of Science ®Google Scholar
• Cross CE, Halliwell B: Nutrition and human disease: how much extra vitamin C might smokers need? Lancet 341: 1091, 1993.
   PubMed Web of Science ®Google Scholar
• Tribble DL, Guiliano LJ, Fortmann SP: Reduced plasma ascorbic acid concentrations in nonsmokers regularly exposed to environmental tobacco smoke. Am J Clin Nutr 58: 886–890, 1993.
   PubMed Web of Science ®Google Scholar
• Gaziano JM, Manson JE, Buring JE, Hennekens CH: Dietary antioxidants and cardiovascular disease. Ann NY Acad Sci 669: 249–258, 1992.
   PubMed Web of Science ®Google Scholar
• Steinberg D, Workshop Participants: Antioxidants in the prevention of human atherosclerosis: summary of the proceedings of a National Heart, Lung, and Blood Institute workshop: September 5–6, 1991, Bethesda, MD. Circulation 85: 2337–2344, 1992.
   PubMed Web of Science ®Google Scholar
• Block G, Sorenson A: Vitamin C intake and dietary sources by demographic characteristics. Nutr Cancer 10: 53–65, 1987.
   PubMedGoogle Scholar
• Cade JE, Margetts BM: Relationship between diet and smoking—is the diet of smokers different? J Epidemiol Commun Health 45: 270–272, 1991.
   PubMed Web of Science ®Google Scholar
• Subar AF, Block G: Use of vitamin and mineral supplements: demographics and amounts of nutrients consumed. The 1987 health interview survey. Am J Epidemiol 132: 1091–1101, 1990.
   PubMed Web of Science ®Google Scholar